Bank Of New York Mellon Corp Ardelyx, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.68 - $4.79 $969,321 - $1.73 Million	361,687 New	361,687 $1.73 Billion
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $440,594 - $1.03 Million	361,143 New	361,143 $1.03 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $28,635 - $69,890	48,535 Added 15.42%	363,314 $432,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $119,868 - $274,993	-235,037 Reduced 42.75%	314,779 $186,000
Q1 2022 May 11, 2022	BUY	$0.65 - $1.18 $159,995 - $290,453	246,147 Added 81.06%	549,816 $588,000
Q4 2021 Feb 11, 2022	BUY	$0.86 - $1.7 $4,191 - $8,285	4,874 Added 1.63%	303,669 $334,000
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $54,477 - $350,460	42,896 Added 16.76%	298,795 $394,000
Q2 2021 Aug 11, 2021	SELL	$6.55 - $8.98 $205,971 - $282,385	-31,446 Reduced 10.94%	255,899 $1.94 Million
Q1 2021 May 13, 2021	SELL	$6.1 - $7.69 $12,090 - $15,241	-1,982 Reduced 0.69%	287,345 $1.9 Million
Q4 2020 Feb 09, 2021	SELL	$5.05 - $7.1 $17,523 - $24,637	-3,470 Reduced 1.19%	289,327 $1.87 Million
Q3 2020 Nov 12, 2020	SELL	$5.25 - $7.08 $15,083 - $20,340	-2,873 Reduced 0.97%	292,797 $1.54 Million
Q2 2020 Aug 12, 2020	BUY	$5.37 - $8.11 $284,561 - $429,757	52,991 Added 21.84%	295,670 $2.05 Million
Q1 2020 May 06, 2020	BUY	$4.35 - $8.79 $251,095 - $507,385	57,723 Added 31.21%	242,679 $1.38 Million
Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $39,000 - $76,433	9,220 Added 5.25%	184,956 $1.39 Million
Q3 2019 Nov 07, 2019	SELL	$2.15 - $6.28 $20,388 - $59,553	-9,483 Reduced 5.12%	175,736 $825,000
Q2 2019 Aug 12, 2019	BUY	$2.49 - $3.73 $39,962 - $59,862	16,049 Added 9.49%	185,219 $498,000
Q1 2019 May 14, 2019	BUY	$1.88 - $3.35 $4,839 - $8,622	2,574 Added 1.55%	169,170 $474,000
Q4 2018 Feb 11, 2019	BUY	$1.66 - $4.16 $28,208 - $70,690	16,993 Added 11.36%	166,596 $298,000
Q3 2018 Nov 09, 2018	BUY	$3.75 - $4.65 $23,861 - $29,587	6,363 Added 4.44%	149,603 $0
Q2 2018 Aug 06, 2018	SELL	$3.7 - $5.8 $102,571 - $160,787	-27,722 Reduced 16.22%	143,240 $530,000
Q1 2018 May 15, 2018	SELL	$5.05 - $7.9 $55,797 - $87,287	-11,049 Reduced 6.07%	170,962 $863,000
Q4 2017 Feb 09, 2018	BUY	$4.85 - $7.8 $882,753 - $1.42 Million	182,011	182,011 $1.2 Million

Others Institutions Holding ARDX

# of Institutions

219

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account